Zydus Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
6,608.50
5,326.60
5,305.20
6,270.70
5,690.20
Other Income Qtr Cr80.6057.5068.2063.20156.40
Operating Revenues Qtr6,527.905,269.105,237.006,207.505,533.80

*All values are in Cr.

Operating Expenses Qtr
4,402.40
3,881.50
3,775.60
4,123.50
3,903.30
Operating Profit Qtr
2,125.50
1,387.60
1,461.40
2,084.00
1,630.50
EBITDA Qtr Cr
1,986.50
1,444.80
1,529.90
2,147.20
1,790.10
Depreciation Qtr
237.90
229.00
233.60
215.30
205.30
Net Profit Qtr
1,170.90
1,026.20
920.20
1,482.50
1,246.10
Basic EPS Qtr
11.64
10.17
9.06
14.11
11.69
Open Demat Account
+91 -

Open Demat Account
+91 -